<DOC>
	<DOCNO>NCT02501564</DOCNO>
	<brief_summary>Osteoarthritis ( OA ) pain treatment limitation term serious adverse effect low efficacy . The investigator aim evaluate efficacy safety naproxen sodium/codeine phosphate combination patient .</brief_summary>
	<brief_title>Evaluation NaproxenSodium CodeinePhosphate Combination Osteoarthritis</brief_title>
	<detailed_description>In prospective , randomize , double blind , placebo control clinical trial , 135 patient osteoarthritis , 40-65 year ; apply institution 's orthopaedics outpatient clinic ; grade 1 , 2 , 3 primary osteoarthritis diagnose last 1 year ; Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) score≥40 , Visual Analogue Scale score≥40 , enrol . Subjects randomize ( 1:1 ) placebo ( n= 67 ) combination ( n= 68 ) arm , 550 mg naproxen sodium/30mg codeine phosphate give orally twice day 7 day . Rescue medicine 500 mg paracetamol ( max= 6 tablets/day ) . Demographic characteristic , medical history , adverse event , VAS WOMAC score collect study visit perform within 10days.The study approve local institutional ethic committee write informed consent obtain participant .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Codeine</mesh_term>
	<criteria>Clinical radiological diagnosis primary osteoarthritis ( knee hip ) recent year accord criterion American College Rheumatology ( ACR ) Grade 1 , 2 3 osteoarthritis patient Patients 40 65 year age Patients WOMAC score ≥ 40 Patients VAS score ≥ 40 Patients signed consent form Grade 4 osteoarthritis patient / Pregnant breastfeeding mother Patients know allergic reaction intolerance NSAIDs ( nonsteroidal antiinflammatory drug ) Patients hypersensitive naproxen sodium codeine Patients take another analgesic medicine 24 hour and/or nonsteroidal antiinflammatory medicine 72 hour take study medicine Patients active gastric duodenum ulcer Patients renal dysfunction and/or kidney disease Patients severe liver disease Patients rare hereditary galactose intolerance , Lapp lactase insufficiency glucosegalactose malabsorption problem Patients depression treat medicine monoamine oxidase class Patients uncontrolled hypertension patient hypertension hardly control medicine Patients know medical , psychological disturbance social status may negatively affect inclusion study patient may lead increase risk others inclusion study Patients prove clinically important unstable systemic medical disease Patients medical contraindication study medicine Patients judge investigator adhere adequately adhere study protocol Patients participate another study another study medicine last 4 week Patients intent donate blood blood product study period follow month study completion</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>NAPROXEN SODIUM</keyword>
</DOC>